Health Care: Drugs

Agenus Inc (AGEN: NASDAQ)

$5.475 0.095 | 1.77%
07/29/16 - 10:36 AM ET
Company Profile
Price and Volume
Recent Price 5.38
52 Week High 8.56
52 Week Low 2.61
Avg. Daily Vol. (Mil) 1.00
Beta (3 year) 1.79
Share Related Items
Mkt Cap (Mil) 467.43
Shares Out (Mil) 86.88
Float (Mil) 83.24
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 5.10
Current Ratio 5.20
LT Debt/ Equity 2.66
Total Debt / Equity 2.66
Valuation Ratios
Price Earnings n.a.
Price/Sales 17.43
Price/Book 10.52
Price/Cash Flow -4.80
Per Share Data
Earnings -1.23
Sales 0.31
Book Value 0.51
Cash Flow -1.13
Business Summary
Agenus Inc along with its subsidiaries is an immuno-oncology company. The Company is engaged in iscovery and development of revolutionary new treatments that engage the body's immune system to benefit patients suffering from cancer.
General Information
3 Forbes Road
Lexington, MA 02421
www.agenusbio.com
Industry : Drugs
Sector: Health Care
Employees: 232
CEO: Dr. Garo H Armen PhD
Short Interest
Current Month (Mil) 7.30
Previous Month (Mil) 7.49
Short Interest Ratio (Days) 7.20
Management Effectiveness
Return on Equity n.a.
Return on Assets -45.60
Return on Investments -62.10
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with AGEN

Latest AGEN Headlines from TheStreet

More Financial News for AGEN

Press Releases for AGEN

See All Press Releases

Partner Headlines for AGEN

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter